IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Free cash flow 2016–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$336.2MFY2025 · since FY2016: -$34.2M → -$336.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$336.2M | +7.6% |
| FY2024 | -$364.0M | +5.2% |
| FY2023 | -$384.1M | -22.6% |
| FY2022 | -$313.2M | -18.0% |
| FY2021 | -$265.5M | -5.4% |
| FY2020 | -$251.9M | -51.9% |
| FY2019 | -$165.8M | -61.8% |
| FY2018 | -$102.4M | -28.5% |
| FY2017 | -$79.7M | -133.2% |
| FY2016 | -$34.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice